The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Background Open-source automated insulin delivery (AID) systems are used by many
patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source …

Advances in diabetes technologies have enabled the development of automated closed-
loop insulin delivery systems. Several hybrid closed-loop systems have been …

A technological solution for the management of diabetes in people who require intensive
insulin therapy has been sought for decades. The last 10 years have seen substantial …

Background A closed-loop system of insulin delivery (also called an artificial pancreas) may
improve glycemic outcomes in children with type 1 diabetes. Methods In a 16-week …

Since the American Diabetes Association (ADA) published the Position Statement “Care of
Children and Adolescents With Type 1 Diabetes”(1) in 2005, innovations have transformed …

Background The achievement of glycaemic control remains challenging for patients with
type 1 diabetes. We assessed the effectiveness of day-and-night hybrid closed-loop insulin …

Background: The safety and effectiveness of the in-home use of a hybrid closed-loop (HCL)
system that automatically increases, decreases, and suspends insulin delivery in response …

Methods| Patients aged 14 to 75 years with type 1 diabetes for at least 2 years, glycated
hemoglobin (HbA1c) less than 10%, and more than 6 months of insulin pump use were …